When a person/entity intends to buy, or sell, a DME company, there are a number of documentation and regulatory issues that must be addressed. The seller must take a number of steps to make itself more attractive. The buyer and seller need to decide whether the transaction will be an asset or stock sale.

The parties will need to engage in multiple transactional steps such as: mutual nondisclosure agreement, letter of intent, stock purchase agreement/asset purchase agreement, and other closing documents. The buyer will need to engage in three types of due diligence: financial, corporate and regulatory. The parties will need to meet a number of regulatory requirements such as submitting change of ownership notifications. This program will discuss all of these (and other) issues associated with the purchase and sale of a DME supplier. Register HERE.

Tuesday, July 25, 2:30-3:30 PM ET
Presented by: Jeffrey Baird, Esq. and Tom Knapp, Esq. of Brown & Fortunato.